HIGHLIGHTS
- who: Ralf S. Eschbach et al. from the University Hospital of Basel, Switzerland have published the paper: Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE, in the Journal: (JOURNAL)
- what: The aim of this study was to compare the SSR-expression of differentiated neuroendocrine tumours (GEP-NET) measured by_[18F]SiTATE-PET/CT in patients with and without previous treatment with long-acting SSAs to evaluate if SSA treatment needs to be paused prior to SiTATE-PET/CT.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.